Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Muscarinic acetylcholine receptor M1 | Starlite/ChEMBL | References |
Rattus norvegicus | Muscarinic acetylcholine receptor M2 | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 150 nM | Binding affinity towards Muscarinic acetylcholine receptor M1 of cerebral cortex | ChEMBL. | 3373484 |
IC50 (binding) | = 150 nM | Binding affinity towards Muscarinic acetylcholine receptor M1 of cerebral cortex | ChEMBL. | 3373484 |
IC50 (binding) | = 600 nM | Binding affinity towards muscarinic receptor of gastric fundus containing Muscarinic acetylcholine receptor M2 | ChEMBL. | 3373484 |
IC50 (binding) | = 600 nM | Binding affinity towards muscarinic receptor of gastric fundus containing Muscarinic acetylcholine receptor M2 | ChEMBL. | 3373484 |
Ratio (binding) | = 4 | Ratio of IC50 (gastric fundus) to IC50 (cortex) | ChEMBL. | 3373484 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.